Using Economic Evaluation to Inform Responses to the Opioid Epidemic in the United States: Challenges and Suggestions for Future Research

References

• Bahorik, A. L., Satre, D. D., Kline-Simon, A. H., Weisner, C. M., & Campbell, C. I. (2017). Alcohol, cannabis, and opioid use disorders, and disease burden in an integrated healthcare system. Journal of Addiction Medicine, 11(1), 3–9. https://doi.org/https://doi.org/10.1097/ADM.0000000000000260
   PubMed Web of Science ®Google Scholar
• Barocas, J. A., White, L. F., Wang, J., Walley, A. Y., LaRochelle, M. R., Bernson, D., Land, T., Morgan, J. R., Samet, J. H., & Linas, B. P. (2018). Estimated prevalence of opioid use disorder in Massachusetts, 2011-2015: A capture-recapture analysis. American Journal of Public Health, 108(12), 1675–1681. https://doi.org/https://doi.org/10.2105/AJPH.2018.304673
   PubMed Web of Science ®Google Scholar
• Beaulieu, E., DiGennaro, C., Stringfellow, E., Connolly, A., Hamilton, A., Hyder, A., Cerdá, M., Keyes, K. M., & Jalali, M. S. (2021). Economic evaluation in opioid modeling: Systematic review. Value in Health, 24(2), 158–173.
   PubMed Web of Science ®Google Scholar
• Bernard, C. L., Owens, D. K., Goldhaber-Fiebert, J. D., & Brandeau, M. L. (2017). Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis. PLoS Medicine, 14(5), e1002312. https://doi.org/https://doi.org/10.1371/journal.pmed.1002312
   PubMed Web of Science ®Google Scholar
• Birger, R. B., Le, T., Kouyos, R. D., Grenfell, B. T., & Hallett, T. B. (2017). The impact of HCV therapy in a high HIV-HCV prevalence population: A modeling study on people who inject drugs in Ho Chi Minh City, Vietnam. PLoS One, 12(5), e0177195. https://doi.org/https://doi.org/10.1371/journal.pone.0177195
   PubMed Web of Science ®Google Scholar
• Bórquez, A., Rich, K., Farrell, M., Degenhardt, L., McKetin, R., Tran, L. T., Cepeda, J., Silva‐Santisteban, A., Konda, K., Cáceres, C. F., Kelly, S., Altice, F. L., & Martin, N. K. (2020). Integrating HIV pre‐exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: A modelling study. Journal of the International AIDS Society, 23(S1), e25495. https://doi.org/https://doi.org/10.1002/jia2.25495
   PubMed Web of Science ®Google Scholar
• Boslett, A. J., Denham, A., & Hill, E. L. (2020). Using contributing causes of death improves prediction of opioid involvement in unclassified drug overdoses in US death records. Addiction, 115(7), 1308–1317.
   PubMed Web of Science ®Google Scholar
• Campo, D. S., Gussler, J. W., Sue, A., Skums, P., & Khudyakov, Y. (2020). Accurate spatiotemporal mapping of drug overdose deaths by machine learning of drug-related web-searches. PLoS One, 15(12), e0243622.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2020). Overdose deaths accelerating during COVID-19. Retrieved July 12, 2021, from https://www.cdc.gov/media/releases/2020/p1218-overdose-deaths-covid-19.html
   Google Scholar
• Centers for Disease Control and Prevention. (2021). Drug overdose deaths. Retrieved July 12, 2021, from https://www.cdc.gov/drugoverdose/deaths/index.html
   Google Scholar
• Centers for Disease Control and Prevention. (2022). https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm, Accessed January 2022.
   Google Scholar
• Cepeda, J. A., Bórquez, A., Magana, C., Vo, A., Rafful, C., Rangel, G., Medina‐Mora, M. E., Strathdee, S., & Martin, N. K. (2020). Modelling integrated antiretroviral treatment and harm reduction services on HIV and overdose among people who inject drugs in Tijuana, Mexico. Journal of the International AIDS Society, 23(S1), e25493. https://doi.org/https://doi.org/10.1002/jia2.25493
   PubMed Web of Science ®Google Scholar
• Ciccarone, D. (2019). The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis. The International Journal on Drug Policy, 71(February), 183–188. https://doi.org/https://doi.org/10.1016/j.drugpo.2019.01.010
   PubMed Web of Science ®Google Scholar
• Ciccarone, D. (2021). The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Current Opinion in Psychiatry, 34(4), 344–350. https://doi.org/https://doi.org/10.1097/YCO.0000000000000717
   PubMed Web of Science ®Google Scholar
• Chambers, J. D., Cangelosi, M. J., & Neumann, P. J. (2015). Medicare’s use of cost-effectiveness analysis for prevention (but not for treatment). Health Policy, 119(2), 156–163.
   Google Scholar
• Compton, W. M., Jones, C. M., Baldwin, G. T., Harding, F. M., Blanco, C., & Wargo, E. M. (2019). Targeting youth to prevent later substance use disorder: An underutilized response to the US opioid crisis. American Journal of Public Health, 109(S3), S185–S189. https://doi.org/https://doi.org/10.2105/AJPH.2019.305020
   PubMed Web of Science ®Google Scholar
• Cousien, A., Tran, V. C., Deuffic‐Burban, S., Jauffret‐Roustide, M., Dhersin, J. S., & Yazdanpanah, Y. (2015). Dynamic modelling of hepatitis C virus transmission among people who inject drugs: A methodological review. Journal of Viral Hepatitis, 22(3), 213–229. https://doi.org/https://doi.org/10.1111/jvh.12337
   PubMed Web of Science ®Google Scholar
• Crowley, D. M., Connell, C. M., Jones, D., & Donovan, M. W. (2019). Considering the child welfare system burden from opioid misuse: Research priorities for estimating public costs. The American Journal of Managed Care, 25(suppl 13), S256–S263.
   PubMedGoogle Scholar
• Culyer, A. J., & Chalkidou, K. (2019). Economic evaluation for health investments En route to universal health coverage: Cost-benefit analysis or cost-effectiveness analysis? Value in Health, 22(1), 99–103. https://doi.org/https://doi.org/10.1016/j.jval.2018.06.005
   PubMed Web of Science ®Google Scholar
• Dasgupta, N., Beletsky, L., & Ciccarone, D. (2018). Opioid crisis: No easy fix to its social and economic determinants. American Journal of Public Health, 108(2), 182–186.
   PubMed Web of Science ®Google Scholar
• Drummond, M. (2013). Twenty years of using economic evaluations for drug reimbursement decisions: what has been achieved?. Journal of health politics, policy and law, 38(6), 1081–1102.
   Google Scholar
• Drummond, M. F. (2020). Modeling in early stages of technology development: Is an iterative approach needed? Comment on "Problems and promises of health technologies: The role of early health economic modeling". International Journal of Health Policy and Management, 9(6), 260–262. https://doi.org/https://doi.org/10.15171/ijhpm.2019.118
   PubMed Web of Science ®Google Scholar
• Ederhof, M. (2021). Why we should standardize provider cost measurement. Health Affairs Blog, September 14, 2021. https://doi.org/https://doi.org/10.1377/hblog20210910.978390
   Google Scholar
• Evans, I., Higgins, F., & Stanford, S. (2019). Local health departments on the front lines of the opioid epidemic. Journal of Public Health Management and Practice, 25(3), 294–296.
   PubMed Web of Science ®Google Scholar
• Fliss, M. D., Cox, M. E., Dorris, S. W., & Austin, A. E. (2021). Timely overdose death reporting is challenging but we must do better. American Journal of Public Health, 111(7), 1194–1196.
   PubMed Web of Science ®Google Scholar
• Florence, C., Luo, F., & Rice, K. (2021). The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017. Drug and Alcohol Dependence, 218, 108350. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2020.108350
   PubMed Web of Science ®Google Scholar
• Fu, R., Owens, D. K., & Brandeau, M. L. (2018). Cost-effectiveness of alternative strategies for provision of HIV pre-exposure prophylaxis for people who inject drugs. AIDS, 32(5), 663–672.
   PubMed Web of Science ®Google Scholar
• Gostin, L. O., Hodge, J. G., & Noe, S. A. (2017). Reframing the opioid epidemic as a national emergency. JAMA, 318(16), 1539–1540.
   PubMed Web of Science ®Google Scholar
• Guthrie, B., Thompson, A., Dumbreck, S., Flynn, A., Alderson, P., Nairn, M., Treweek, S., & Payne, K. (2017). Better guidelines for better care: Accounting for multimorbidity in clinical guidelines – structured examination of exemplar guidelines and health economic modelling. Health Services and Delivery Research, 5(16), 1–150. https://doi.org/https://doi.org/10.3310/hsdr05160
   Google Scholar
• Idris, I. (2018). Cost-effectiveness in humanitarian work: Preparedness, pre-financing and early action. University of Birmingham. Retrieved July 12, 2021, from https://opendocs.ids.ac.uk/opendocs/bitstream/handle/20.500.12413/14218/461_Cost_Effectiveness_in_ Humanitarian_Work_Preparedness_Pre-financing_and_Early_Action.pdf?sequence=1
   Google Scholar
• Institute for Clinical and Economic Review. (2020). Assessments. Institute for Clinical and Economic Review. Retrieved July 12, 2021, from https://icer.org/explore-our-research/assessments/
   Google Scholar
• Jalal, H., & Burke, D. S. (2021). Carfentanil and the rise and fall of overdose deaths in the United States. Addiction, 116(6), 1593–1599.
   PubMed Web of Science ®Google Scholar
• Jones, H. E., Harris, R. J., Downing, B. C., Pierce, M., Millar, T., Ades, A. E., Welton, N. J., Presanis, A. M., De Angelis, D., & Hickman, M. (2020). Estimating the prevalence of problem drug use from drug‐related mortality data. Addiction, 115(12), 2393–2404.
   PubMed Web of Science ®Google Scholar
• Khatri, U. G., & Perrone, J. (2020). Opioid use disorder and COVID-19: Crashing of the crises. Journal of Addiction Medicine, 14(4), e6–e7. https://doi.org/https://doi.org/10.1097/ADM.0000000000000684
   PubMed Web of Science ®Google Scholar
• Koh, H. K. (2017). Community-based prevention and strategies for the opioid crisis. JAMA, 318(11), 993–994. https://doi.org/https://doi.org/10.1001/jama.2017.13767
   PubMed Web of Science ®Google Scholar
• Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015). The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review of Public Health, 36(1), 559–574. https://doi.org/https://doi.org/10.1146/annurev-publhealth-031914-122957
   PubMed Web of Science ®Google Scholar
• Larney, S., & Hall, W. (2019). A major expansion of opioid agonist treatment is needed to reduce overdose deaths in the USA. The Lancet Public Health, 4(2), e77–e78. https://doi.org/https://doi.org/10.1016/S2468-2667(19)30001-5
   PubMed Web of Science ®Google Scholar
• Lee, T. T., Gluck, A. R., & Curfman, G. (2016). The politics of Medicare and drug-price negotiation (updated). Health Affairs Blog, Oct, 20.
   Google Scholar
• Leslie, D. L., Ba, D. M., Agbese, E., Xing, X., & Liu, G. (2019). The economic burden of the opioid epidemic on states: The case of Medicaid. The American Journal of Managed Care, 25(13 Suppl), S243–S249.
   PubMedGoogle Scholar
• Marks, C., Abramovitz, D., Donnelly, C. A., Carrasco-Escobar, G., Carrasco-Hernández, R., Ciccarone, D., González-Izquierdo, A., Martin, N. K., Strathdee, S. A., Smith, D. M., & Bórquez, A. (2021b). Identifying counties at risk of high overdose mortality burden during the emerging fentanyl epidemic in the USA: A predictive statistical modelling study. The Lancet Public Health, 6(10), e720–e728. https://doi.org/https://doi.org/10.1016/S2468-2667(21)00080-3
   PubMed Web of Science ®Google Scholar
• Marks, C., Carrasco-Escobar, G., Carrasco-Hernández, R., Johnson, D., Ciccarone, D., Strathdee, S. A., Smith, D., & Bórquez, A. (2021a). Methodological approaches for the prediction of opioid use-related epidemics in the United States: A narrative review and cross-disciplinary call to action. Translational Research, 234, 88–113. https://doi.org/https://doi.org/10.1016/j.trsl.2021.03.018
   PubMed Web of Science ®Google Scholar
• Neumann, P. J. (2004). Why don’t Americans use cost-effectiveness analysis. The American Journal of Managed Care, 10(5), 308–312.
   Google Scholar
• Onuoha, E. N., Leff, J. A., Schackman, B. R., McCollister, K. E., Polsky, D., & Murphy, S. M. (2021). Economic evaluations of pharmacologic treatment for opioid use disorder: A systematic literature review. Value in Health, 24(7), 1068–1083. https://doi.org/https://doi.org/10.1016/j.jval.2020.12.023
   PubMed Web of Science ®Google Scholar
• Park, J. N., Rouhani, S., Beletsky, L., Vincent, L., Saloner, B., & Sherman, S. G. (2020). Situating the continuum of overdose risk in the social determinants of health: A new conceptual framework. The Milbank Quarterly, 98(3), 700–746.
   PubMed Web of Science ®Google Scholar
• Parker, C. M., Hirsch, J. S., Hansen, H. B., Branas, C., & Martins, S. S. (2019). Facing opioids in the shadow of the HIV epidemic. New England Journal of Medicine, 380(1), 1–3. https://doi.org/https://doi.org/10.1056/NEJMp1813836
   PubMed Web of Science ®Google Scholar
• Pizzi, L. T. (2016). The Institute for Clinical and Economic Review and its growing influence on the US healthcare. American Health & Drug Benefits, 9(1), 9–10.
   PubMed Web of Science ®Google Scholar
• Raja, K., Higgins, F., & Hall, K. (2019). Local health department approaches to opioid use prevention and response: An environmental scan. National Association of County and City Health Officials. Retrieved July 12, 2020, from https://www.naccho.org/uploads/downloadable-resources/Environmental-Scan-V3-July-2019-FINAL-v2.pdf
   Google Scholar
• Ramponi, F., Walker, S., Griffin, S., Parrott, S., Drummond, C., Deluca, P., Coulton, S., Kanaan, M., & Richardson, G. (2021). Cost-effectiveness analysis of public health interventions with impacts on health and criminal justice: An applied cross-sectoral analysis of an alcohol misuse intervention. Health Economics, 30(5), 972–988. https://doi.org/https://doi.org/10.1002/hec.4229
   PubMed Web of Science ®Google Scholar
• Ropero‐Miller, J. D., Smiley‐McDonald, H. M., Zimmer, S. A., & Bollinger, K. M. (2020). A Census of medicolegal death investigation in the United States: A need to determine the state of our nation’s toxicology laboratories and their preparedness for the current drug overdose epidemic. Journal of Forensic Sciences, 65(2), 544–549. https://doi.org/https://doi.org/10.1111/1556-4029.14277
   PubMed Web of Science ®Google Scholar
• Rosenblum, D., Unick, J., & Ciccarone, D. (2020). The rapidly changing US illicit drug market and the potential for an improved early warning system: Evidence from Ohio drug crime labs. Drug and Alcohol Dependence, 208, 107779.
   PubMed Web of Science ®Google Scholar
• Rouhani, S., Park, J. N., Morales, K. B., Green, T. C., & Sherman, S. G. (2019). Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence. Harm Reduction Journal, 16(1), 39. https://doi.org/https://doi.org/10.1186/s12954-019-0311-9
   PubMed Web of Science ®Google Scholar
• Schimmel, J., & Manini, A. F. (2020). Opioid use disorder and COVID-19: Biological plausibility for worsened outcomes. Substance Use & Misuse, 55(11), 1900–1901. https://doi.org/https://doi.org/10.1080/10826084.2020.1791184
   PubMed Web of Science ®Google Scholar
• Sculpher, M. J., & Drummond, M. F. (2006). Analysis sans frontières: Can we ever make economic evaluations generalisable across jurisdictions?. PharmacoEconomics, 24(11), 1087–1099.
   PubMed Web of Science ®Google Scholar
• Segel, J. E., Shi, Y., Moran, J. R., & Scanlon, D. P. (2019a). Revenue losses to state and federal government from opioid-related employment reductions. Medical Care, 57(7), 494–497. https://doi.org/https://doi.org/10.1097/MLR.0000000000001107
   PubMed Web of Science ®Google Scholar
• Segel, J. E., Shi, Y., Moran, J. R., & Scanlon, D. P. (2019b). Opioid misuse, labor market outcomes, and means-tested public expenditures: A conceptual framework. The American Journal of Managed Care, 25(suppl 13), S270–S276.
   PubMedGoogle Scholar
• Stuart, R. M., & Wilson, D. P. (2020). Sharing the costs of structural interventions: What can models tell us? International Journal of Drug Policy, 88, 102702.
   PubMed Web of Science ®Google Scholar
• Sumetsky, N., Mair, C., Wheeler-Martin, K., Cerda, M., Waller, L. A., Ponicki, W. R., & Gruenewald, P. J. (2021). Predicting the future course of opioid overdose mortality: An example from two US states. Epidemiology, 32(1), 61–69. https://doi.org/https://doi.org/10.1097/EDE.0000000000001264
   PubMed Web of Science ®Google Scholar
• Tappenden, P., Chilcott, J., Brennan, A., Squires, H., & Stevenson, M. (2012). Whole disease modeling to inform resource allocation decisions in cancer: A methodological framework. Value in Health, 15(8), 1127–1136.
   PubMed Web of Science ®Google Scholar
• Teutsch, S. M., & Fielding, J. (2016). Economics and local public health departments. American Journal of Preventive Medicine, 50(5 Suppl 1), S81–S83.
   PubMed Web of Science ®Google Scholar
• Thokala, P., Carlson, J. J., & Drummond, M. (2020). HTA’d in the USA: A comparison of ICER in the United States with NICE in England and Wales. Journal of Managed Care & Specialty Pharmacy, 26(9), 1162–1170. https://doi.org/https://doi.org/10.18553/jmcp.2020.26.9.1162
   PubMed Web of Science ®Google Scholar
• Thomas, C. P., Kim, M., Nikitin, R. V., Kreiner, P., Clark, T. W., & Carrow, G. M. (2014). Prescriber response to unsolicited prescription drug monitoring program reports in Massachusetts. Pharmacoepidemiology and Drug Safety, 23(9), 950–957.
   PubMed Web of Science ®Google Scholar
• Travis, J., Western, B., & Redburn, F. S. (2014). The growth of incarceration in the United States: Exploring causes and consequences. Washington, DC: The National Academies Press. https://doi.org/https://doi.org/10.17226/18613.
   Google Scholar
• Van Handel, M. M., Rose, C. E., Hallisey, E. J., Kolling, J. L., Zibbell, J. E., Lewis, B., Bohm, M. K., Jones, C. M., Flanagan, B. E., Siddiqi, A-E-A., Iqbal, K., Dent, A. L., Mermin, J. H., McCray, E., Ward, J. W., & Brooks, J. T. (2016). County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. Journal of Acquired Immune Deficiency Syndromes (1999), 73(3), 323–331. https://doi.org/https://doi.org/10.1097/QAI.0000000000001098
   PubMed Web of Science ®Google Scholar
• Vorhies, F. (2012). The economics of investing in disaster risk reduction. UN International Strategy for Disaster Reduction. Retrieved July 12, 2021, from https://www.preventionweb.net/posthfa/documents/drreconomicsworkingpaperfinal.pdf
   Google Scholar
• Wakeman, S. E., Green, T. C., & Rich, J. D. (2014). From documenting death to comprehensive care: Applying lessons from the HIV/AIDS epidemic to addiction. The American Journal of Medicine, 127(6), 465–466. https://doi.org/https://doi.org/10.1016/j.amjmed.2013.12.018
   PubMed Web of Science ®Google Scholar
• Walker, S., Griffin, S., Asaria, M., Tsuchiya, A., & Sculpher, M. (2019). Striving for a societal perspective: A framework for economic evaluations when costs and effects fall on multiple sectors and decision makers. Applied Health Economics and Health Policy, 17(5), 577–590.
   PubMed Web of Science ®Google Scholar
• Williams, K. E., Freeman, M. D., & Mirigian, L. (2017). Drug overdose surveillance and information sharing via a public database: The role of the medical examiner/coroner. Academic Forensic Pathology, 7(1), 60–72. https://doi.org/https://doi.org/10.23907/2017.007
   PubMedGoogle Scholar